Pharmaceutical industry news

Boletín sobre Seguridad de Medicamentos de Uso Humano. Junio de 2026

Krystal Biotech Q2 revenue rises to $119.2 million on VYJUVEK sales

FDA Weight Loss Approved Drugs: Evidence-Based Options for Safe, Sustainable Results *9RAcMCjbF*

Krystal Biotech, Inc. Quarterly Earnings Report

CHO perfusion model lifts yield by letting cellular waste build up

Opus Genetics expects data in 2027 from one-time gene therapy trial

Opus Genetics Completes Patient Enrollment in

What would it take to get peptides on the shelf?

FDA Panel Ignites Debate Over Controversial Peptide Treatments

TG Therapeutics Reports Second Quarter 2026 Financial Results and Raises BRIUMVI® Revenue Guidance

Can-Fite Launches First Clinical Program for Piclidenoson in the Rare Genetic Disease Lowe Syndrome

Over the Counter Weight Loss Medication: What Works, What Doesn’t, and How to Pick a Safe Option in 2026 *0oSGFEEPg*

Online platform agrees to stop selling GLP-1 drugs to US customers

Harbour BioMed and Kelun-Biotech receive China IND approval for bispecific asthma therapy

IPO News - IPO Winners & Losers: Biotech Soars, Jersey Mike's Misses, and SpaceX Faces the Lockup

Administrative – Government’s restrictions on mifepristone are arbitrary and capricious

Retatrutide Weight Loss Jacksonville - View HburRYuVY

Partnership to create AI chemical data ecosystem

FDA Approved Weight Loss Patch: What It Is and Why It Matters (or Doesn't) - View rwF6IMi5Z

Exec on Execs: China's Rise in Biotech Investment

116,100 Shares in Teva Pharmaceutical Industries Ltd. $TEVA Bought by Militia Capital Management LLC

Varda Announces Biopharma Leader Mikael Dolsten will Join Board as Space-Based Pharmaceutical Manufacturing Accelerates

This Next-Gen GLP-1 Is Blowing Up the Black Market Economy

South Africa Prepares for Potential New Adult TB Vaccine

Jeol launches two high-resolution microscopes

Radiopharm (ASX:RAD) Expands Clinical Momentum with Positive Trial Updates

What will health and social care look like under Andy Burnham?

Retatrutide Weight Loss Price: What It Costs in 2026 and Why It Matters - View 9UjQdSwbZ

Pharmaceutical Weight Loss - View BUEiBWgjg

IMPACT licenses ovarian cancer drug senaparib to Pharmanovia

FDA Approved Weight Loss Medications List - View UYywmxlnc

Unlocking peptide permeability with high-throughput SFC-EPSA analysis

Breast Cancer Trial Highlights Promise and Risks of Dual Immunotherapy

Billionaire Stanley Druckenmiller Bought This Biotech Stock That Has Surged 400%. Is It Still a Buy?

Sven Borho steps down from Worldwide Health with Biotech Growth's Hsu becoming co-manager

AstraZeneca And BMS In Talks Over Major Pharmaceutical Merger

Regulatory round-up: 3 August 2026

Ractigen wins FDA IND clearance for saRNA candidate

AstraZeneca ‘in talks to create £300bn pharmaceutical giant’

Dongkook Pharm Nears W1 Trillion Sales Milestone

Pneumococcal polysaccharide conjugate vaccine (PCV20) PGD template

Patient group direction (PGD) template to support the provision of pneumococcal polysaccharide conju...

PCV (13-valent or 15-valent, adsorbed): patient group direction (PGD) template

PGD template to support the national pneumococcal polysaccharide conjugate vaccine (13-valent or 15-...

DHSC privacy notice

Find out about DHSC's data protection policy and procedures.

Department of Health and Social Care record of processing activity (RoPA)

The record of processing activity lists the personal data being held and processed by the Department...

BCG Vaccine AJV: patient group direction (PGD) template

PGD template to support the administration of BCG Vaccine AJV to individuals under 16 years of age a...

Billionaire Stanley Druckenmiller Bought This Biotech Stock That Has Surged 400%. Is It Still a Buy?

Billionaire Stanley Druckenmiller Bought This Biotech Stock That Has Surged 400%. Is It Still a Buy?

South Africa prepares for potential breakthrough adult TB vaccine

Media: AstraZeneca and Bristol Myers hold mega-merger talks

One of China’s major pharmaceutical companies joined Belarusian stock market

Dr. Ram Sarma Joins Virchow Biotech as Chief Operating Officer

ZEUS delivers a bolt of pain to Novo Nordisk

Retatrutide for Weight Loss: What the Phase 3 Data Really Shows - View ykRgGbybc

AstraZeneca, Bristol Myers Squibb Discuss Mega-Merger

Weight Loss Pharmaceutical Drugs: What They Are, How They Work, and Realistic Expectations *mp8ZQmYHf*

Investor lawsuit looms: Lawyer predicts three consequences for Novo Nordisk

Teva Pharmaceutical Industries Ltd. $TEVA Shares Sold by Amundi

Montana’s new “right to try”: Opening the door to profit from unproven drugs

Sun Pharmaceutical Industries shares fall 2% in early trade

Mesoblast’s Ryoncil Posts $115M First-Year Revenue on Pediatric Approval